BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21480809)

  • 1. Dysarthria in stroke: a narrative review of its description and the outcome of intervention.
    Mackenzie C
    Int J Speech Lang Pathol; 2011 Apr; 13(2):125-36. PubMed ID: 21480809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved status following behavioural intervention in a case of severe dysarthria with stroke aetiology.
    Mackenzie C; Lowit A
    Int J Speech Lang Pathol; 2012 Aug; 14(4):318-28. PubMed ID: 22348261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left-hemispheric dominance for articulation: a prospective study on acute ischaemic dysarthria at different localizations.
    Urban PP; Rolke R; Wicht S; Keilmann A; Stoeter P; Hopf HC; Dieterich M
    Brain; 2006 Mar; 129(Pt 3):767-77. PubMed ID: 16418180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysarthria due to supratentorial and infratentorial ischemic stroke: a diffusion-weighted imaging study.
    Kumral E; Celebisoy M; Celebisoy N; Canbaz DH; Calli C
    Cerebrovasc Dis; 2007; 23(5-6):331-8. PubMed ID: 17268163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acoustic analysis of voice in dysarthria following stroke.
    Wang YT; Kent RD; Kent JF; Duffy JR; Thomas JE
    Clin Linguist Phon; 2009 May; 23(5):335-47. PubMed ID: 19399666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-thinking diagnostic classification of the dysarthrias: a developmental perspective.
    Morgan AT; LiƩgeois F
    Folia Phoniatr Logop; 2010; 62(3):120-6. PubMed ID: 20424467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired corticolingual pathways in patients with or without dysarthria after acute monohemispheric stroke.
    Khedr EM; Abdel-Fadeil MR; El-Khilli F; Ibrahim MQ
    Neurophysiol Clin; 2005 Jul; 35(2-3):73-80. PubMed ID: 16087070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysarthria and mutism.
    Sternic N; Mijajlovic M; Tomic G; Pavlovic A
    Front Neurol Neurosci; 2012; 30():83-5. PubMed ID: 22377870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Parkinsonian dysarthria].
    Gentil M; Pollak P; Perret J
    Rev Neurol (Paris); 1995 Feb; 151(2):105-12. PubMed ID: 7676137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysarthria in amyotrophic lateral sclerosis: A review.
    Tomik B; Guiloff RJ
    Amyotroph Lateral Scler; 2010; 11(1-2):4-15. PubMed ID: 20184513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Cochrane review of treatment for dysarthria following acquired brain injury in children and adolescents.
    Morgan AT; Vogel AP
    Eur J Phys Rehabil Med; 2009 Jun; 45(2):197-204. PubMed ID: 19156018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing obesity and related chronic disease risk in children and youth: a synthesis of evidence with 'best practice' recommendations.
    Flynn MA; McNeil DA; Maloff B; Mutasingwa D; Wu M; Ford C; Tough SC
    Obes Rev; 2006 Feb; 7 Suppl 1():7-66. PubMed ID: 16371076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and clinical presentation of dysarthria and dysphagia in the acute setting following paediatric traumatic brain injury.
    Morgan AT; Mageandran SD; Mei C
    Child Care Health Dev; 2010 Jan; 36(1):44-53. PubMed ID: 19320903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cerebellar dysarthria--a review of the literature].
    Ackermann H; Ziegler W
    Fortschr Neurol Psychiatr; 1992 Jan; 60(1):28-40. PubMed ID: 1544617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palliative treatment of dysphonia and dysarthria.
    Cohen SM; Elackattu A; Noordzij JP; Walsh MJ; Langmore SE
    Otolaryngol Clin North Am; 2009 Feb; 42(1):107-21, x. PubMed ID: 19134494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes to articulation following LSVT(R) and traditional dysarthria therapy in non-progressive dysarthria.
    Wenke RJ; Cornwell P; Theodoros DG
    Int J Speech Lang Pathol; 2010 Jun; 12(3):203-20. PubMed ID: 20433339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term effects of repetitive transcranial magnetic stimulation on speech and voice in individuals with Parkinson's disease.
    Hartelius L; Svantesson P; Hedlund A; Holmberg B; Revesz D; Thorlin T
    Folia Phoniatr Logop; 2010; 62(3):104-9. PubMed ID: 20424465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Speech-language pathology and dysphagia in multiple sclerosis.
    Merson RM; Rolnick MI
    Phys Med Rehabil Clin N Am; 1998 Aug; 9(3):631-41. PubMed ID: 9894114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dysarthria across Parkinson's disease progression. Natural history of its components: dysphonia, dysprosody and dysarthria].
    Pinto S; Ghio A; Teston B; Viallet F
    Rev Neurol (Paris); 2010 Oct; 166(10):800-10. PubMed ID: 20800250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orofacial myofunctional therapy in dysarthria: a study on speech intelligibility.
    Ray J
    Int J Orofacial Myology; 2002 Nov; 28():39-48. PubMed ID: 12572259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.